BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31531019)

  • 1.
    Stepp MW; Salazar-González RA; Hong KU; Doll MA; Hein DW
    J Oncol; 2019; 2019():3860426. PubMed ID: 31531019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Arylamine
    Carlisle SM; Trainor PJ; Doll MA; Hein DW
    Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable Isotope Tracing Reveals an Altered Fate of Glucose in
    Wise JTF; Yin X; Ma X; Zhang X; Hein DW
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
    Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
    Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Toxicol Rep; 2022; 9():1566-1573. PubMed ID: 36158865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dataset for proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Data Brief; 2022 Dec; 45():108634. PubMed ID: 36426076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylamine
    Salazar-González RA; Doll MA; Hein DW
    Front Pharmacol; 2022; 13():797469. PubMed ID: 35153780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl coenzyme A kinetic studies on
    Habil MR; Doll MA; Hein DW
    Front Pharmacol; 2022; 13():931323. PubMed ID: 36386142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
    Butcher NJ; Ilett KF; Minchin RF
    Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.
    Stepp MW; Mamaliga G; Doll MA; States JC; Hein DW
    Biochem Biophys Rep; 2015 Sep; 3():45-50. PubMed ID: 26309907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
    Li P; Butcher NJ; Minchin RF
    Cell Adh Migr; 2020 Dec; 14(1):1-11. PubMed ID: 31910058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
    Sinclair J; Sim E
    Biochem Pharmacol; 1997 Jan; 53(1):11-6. PubMed ID: 8960058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.